CANLI
Yükleniyor Veriler getiriliyor…
/ Makaleler / Scopus Detay
Scopus 🔓 Açık Erişim YÖKSİS DOI Eşleşti SJR Q3

Characteristics of Radiopharmaceutical Uptake in Primary Tumor and Metastatic Lesions of Prostate Carcinoma: Comparison of Oligometastatic with Multimetastatic Disease

Molecular Imaging and Radionuclide Therapy · Şubat 2023

YÖKSİS DOI Eşleşmesi Bulundu

Bu Scopus makalesi YÖKSİS veritabanında da kayıtlı. Aşağıda YÖKSİS verilerini görebilirsiniz.

YÖKSİS Kayıtları
Characteristics of Radiopharmaceutical Uptake in Primary Tumor and Metastatic Lesions of Prostate Carcinoma: Comparison of Oligometastatic with Multimetastatic Disease
Molecular Imaging and Radionuclide Therapy · 2023 Emerging sources citation index
Doç. Dr. HASAN ÖNNER →
YÖKSİS ISSN Eşleşmesi

Bu dergide (ISSN eşleşmesi) kurumun 7 kaydı bulundu.

YÖKSİS Kayıtları — ISSN Eşleşmesi
68Ga-PSMA-Avid Sinonasal Intestinal-Type Adenocarcinoma
2025 ISSN: 2146-1414 ESCI
Dr. Öğr. Üyesi MUHAMMET FATİH GÖKMEN →
The Role of Histogram-Based Textural Analysis of 18F-FDG PET/CT in Evaluating Tumor Heterogeneity and Predicting the Prognosis of Invasive Lung Adenocarcinoma
2022 ISSN: 2146-1414 ESCI
Doç. Dr. HASAN ÖNNER →
Characteristics of Radiopharmaceutical Uptake in Primary Tumor and Metastatic Lesions of Prostate Carcinoma: Comparison of Oligometastatic with Multimetastatic Disease
2023 ISSN: 2146-1414 Emerging sources citation index
Doç. Dr. HASAN ÖNNER →
Physiological Biodistribution of 68Ga-DOTA-TATE in Normal Subjects
2021 ISSN: 2146-1414 ESCI
Dr. Öğr. Üyesi KEVSER ÖKSÜZOĞLU →
Nasolacrimal Duct Obstruction on <sup>131</sup>I SPECT/CT: Atypical False-positive Paranasal Radioiodine Uptake as a Complication of Single-dose RAI Treatment
2022 ISSN: 2146-1414 ESCI
Dr. Öğr. Üyesi KEVSER ÖKSÜZOĞLU →
Extensive Malignant Thrombus Revealed by 18F-FDG PET/CT in Patient with Papillary Thyroid Cancer
2025 ISSN: 2146-1414 ESCI
Doç. Dr. HASAN ÖNNER →
Comparison of 68Ga-FAPI-04 and 68Ga-PSMA in a Case of Interstitial Lung Disease
2025 ISSN: 2146-1414 ESCI
Doç. Dr. HASAN ÖNNER →

Makale Bilgileri

Dergi Molecular Imaging and Radionuclide Therapy
ISSN21461414
Yayın TarihiŞubat 2023
Cilt / Sayfa32 · 20-27
DOI10.4274/mirt.galenos.2022.71463
Scopus ID2-s2.0-85149467835
Erişim🔓 Açık Erişim
Özet Objectives: Oligometastases may generate secondary to indolent tumor biology. In this study, we investigated whether semiquantitative measures of18F-fluorodeoxyglucose (FDG) and gallium-68 (68Ga) prostate-specific membrane antigen (PSMA) uptake of metastatic lesions and prostatic sites are different between oligometastatic (OM) and multimetastatic (MM) disease of prostate carcinoma (PC). Methods: Patients with PC, who underwent positron emission tomography/computed tomography (PET/CT) from October 2012 to February 2020 were retrospectively reviewed. Patients, whose reports were consistent with metastatic diseases were selected. Patients classified as with MM or OM disease. Maximum standardized uptake values (SUVmax) were calculated from metastatic lesions and the prostatic site. The median of the SUVmax results between patients with OM and MM disease were compared. Results: A totally 145 patients with a mean age of 71.46±9.26, were evaluated. In 59 of 145 patients,18F-FDG PET/CT was performed; 86 patients had gone through68Ga PSMA PET/CT. Thirty-seven of 145 patients were OM, whereas 108 patients were MM. The median of the SUVmax of metastatic lesions in patients with OM and MM disease in the18F-FDG group were 5.60 and 9.51, respectively. The results of the calculated median SUVmax values in OM and MM disease in the Ga-68 PSMA group were 13.44 and 29.84, respectively. A significant difference was observed in the median SUVmax results of metastatic lesions between OM and MM disease (p<0.05). Median values of SUVmax calculated from the prostatic site in OM and MM disease were 7.83 and 12.29 respectively in18F-FDG; 26.23 and 26.74 in the 68 Ga PSMA group. No significant difference was found in the SUVmax results of the prostatic site between OM and MM disease (p>0.05). Conclusion: SUVmax results of metastatic lesions are significantly higher in patients with MM than in patients with OM disease in patients with PC, which may be secondary to their different biological contents in terms of aggressiveness.

Yazarlar (3)

1
G. K. Gedik
2
F. Yilmaz
3
H. Önner
ORCID: 0000-0003-1002-2097

Anahtar Kelimeler

Oligometastasis PET/CT prostate carcinoma SUV max

Kurumlar

Selçuk Tip Fakültesi
Konya Turkey
Scimago Dergi (ISSN Eşleşmesi)
Molecular Imaging and Radionuclide Therapy
Q3 OA
SJR Skoru0,274
H-Index17
YayıncıGalenos Publishing House
ÜlkeTurkey
Radiology, Nuclear Medicine and Imaging (Q3)
Dergi sayfasına git

Hızlı Erişim

DOI ile aç Scopus'ta aç Makaleler listesi